Helix BioPharma Corp. to Present at the Noble Capital Markets’ Sixteenth Annual Investor Conference

RICHMOND HILL, Ontario, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that Dr. Heman Chao, Helix’s Chief Executive Officer, will be presenting at NobleCon - Noble Capital Markets’ Sixteenth Annual Investor Conference at the Hard Rock Hotel & Casino, Hollywood, Florida - on Monday, February 17^th at 3:00PM Eastern Standard Time (https://www.nobleconference.com/sixteen#home).

In addition to the company’s presentation on Monday, February 17^th Dr. Chao has been invited to be a panelist on “Cancer Treatment: Tackling the Disease Through Innovative Strategies”. The panel discussion is being held on February 17^th between 5:30pm and 6:30pm in Terrace Ballroom D.  The panel will discuss current revolutionary new strategies to defeat cancer, including innate immunity, modulation of tumor micro-environment, treatment of solid tumors with CAR-T, cancer vaccines and cell cycle inhibitors.  

Furthermore, Helix has been selected to present to Noble Capital Markets Life Sciences Scientific and Advisory Board (“LSAB”), in an invitation only event.  Noble Capital Markets’ LSAB is composed of world-class healthcare professionals with extensive experience in the medical and pharmaceutical industries.

“We are very pleased to be presenting at this conference in addition to having been invited to partake in a panel discussion and to present Helix’s technology to Noble Capital Markets Life Sciences Scientific and Advisory Board”, said Dr. Chao.  “We look forward to introducing Helix to a wider investment community”.

A high-definition video of Helix’s presentation will be available the following day on the Company's website at www.helixbiopharma.com and will also be available on Noble Capital Markets’ conference website at www.nobleconference.com as part of the conference’s complete catalogue of presentations and on Noble Capital Markets’ investor portal website, Channelchek, at www.channelchek.com.

About NobleCon

Noble Capital Markets' 16th Annual Emerging Growth Investor Conference - a multi-sector blend of emerging growth companies with total representation limited to 125 public companies. Four presentation tracks run simultaneously each half hour over two days. One-on-one meetings between qualified investors and corporate executives are arranged and scheduled on behalf of participants. Topical panel presentations open to all attendees. Comprehensive evening networking events. Registration for investors is open to institutions, registered investment advisors, family offices, self-directed high-net-worth individuals and independent brokers.